BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Enveric Biosciences Divests Cancer-Targeting Cannabinoid IP to Focus on Mental Health Therapeutics

Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...

February 26, 2024 | News

Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development

This latest phase involves development of an additional Optimer binder against the innovative Neuro-Bio target implicated in Alzheimer’s disease, wit...

February 23, 2024 | News

Thermo Fisher Scientific Awards Latest Oncomine Clinical Research Grants to Propel Oncology Advances

Thermo Fisher Scientific has unveiled the latest recipients of its Oncomine Clinical Research Grant, a prestigious accolade dedicated to advancing research...

February 21, 2024 | News

GSK Secures License for Elsie Biotechnologies' Cutting-Edge Discovery Platform

Kevin Green, Chief Operating Officer of Elsie Biotechnologies, expressed enthusiasm, stating, "We are pleased that GSK ha...

February 15, 2024 | News

Gilead Sciences Bolsters Liver Portfolio Through Acquisition of CymaBay Therapeutics

Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced today a definitive agreement whereby Gilead will acquire CymaBay for $32.50 ...

February 13, 2024 | News

Novo Nordisk's Investment Arm, Novo Holdings, Seals $16.5 Billion Deal to Acquire Catalent in All-Cash Transaction

Catalent, Inc. (NYSE: CTLT), a prominent player in advancing global patient treatment solutions, and Novo Holdings, a holding and investment entity oversee...

February 06, 2024 | News

John Graham, Zuellig Pharma Group CEO, Explores Strategic Partnership with Substipharm Biologics to Transform Healthcare in Asia

In an insightful interview with BioPharma APAC, John Graham, Group CEO of Zuellig Pharma, shares details about the strategic partnership with Substipharm B...

February 05, 2024 | Interaction

World Cancer Day 2024: WHO Regional Director Urges Collective Action for a Cancer-Free Africa

The cancer situation in Africa is alarming, with 1.1 million new cases and 700,000 deaths in 2020. Breast, cervical, prostate, colorectal, and live...

February 04, 2024 | News

Revvity CEO Prahlad Singh Highlights Resilience and Innovation Amidst Industry Challenges in 2023

Revvity, Inc. (NYSE: RVTY) announced robust financial results for Q4 2023 and the full year ending December 31, 2023. Fourth Quarter 2023 Highlights: ...

February 02, 2024 | Company results

LabCorp Launches New Test for Severe Preeclampsia Risk in Pregnant Women

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the launch and availability of a new, FDA-cle...

February 01, 2024 | News

Amcor Expands Thermoforming Capacity for Healthcare Growth in North America

The addition of automated, state-of-the art thermoforming equipment at Amcor's world-class healthcare manufacturing plant in Oshkosh, Wisconsin w...

February 01, 2024 | News

Merck Launches Digital Hub in Singapore to Drive Healthcare and Semiconductor Innovations Globally

Hub to drive innovation and research in healthcare and semi-conductor industries with Syntropy™ and Athinia™ platforms Forms a glo...

January 31, 2024 | News

Vertex's Breakthrough VX-548: Transforming Pain Management with Rapid Relief and Safety, A New Era in Acute Pain Solutions

Treatment with VX-548 led to statistically significant improvement in pain compared to placebo as well as a clinically meaningful reduction in pain from ...

January 31, 2024 | News

Catalent Pledges to Slash Greenhouse Gas Emissions by 2030

Catalent, Inc. the leader in enabling the development and supply of better treatments for patients worldwide, announced its targets to reduce greenho...

January 26, 2024 | News

Stay Connected